Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Chamberlain

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Archives of Neurology|September 1, 1995
Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastasesM C Chamberlain, P Kormanik, S B Howell, et al.
Neurosurgery|October 1, 1988
Treatment of extraneural metastatic medulloblastoma with a combination of cyclophosphamide, adriamycin, and vincristineM C Chamberlain, P Silver, M S Edwards, et al.
Neuro-Oncology|April 18, 2001
Adult medulloblastoma: multiagent chemotherapyH S Greenberg, M C Chamberlain, M J Glantz, et al.
Journal of Neuro-Oncology|December 1, 1988
A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumorsM C Chamberlain, M D Prados, P Silver, et al.
American Journal of Clinical Oncology|February 1, 1988
A phase II trial of oral melphalan in recurrent primary brain tumorsM C Chamberlain, M D Prados, P Silver, et al.
Journal of Neuro-Oncology|March 1, 1996
Spindle cell hemangioendothelioma of the spinal cordZ Mahdavi, M R Grafe, R Ostrup, et al.
Archives of Neurology|March 1, 1993
Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I studyM C Chamberlain, S Khatibi, J C Kim, et al.
Seminars in Radiation Oncology|April 21, 1999
The role of paclitaxel in the treatment of primary and metastatic brain tumorsM J Glantz, M C Chamberlain, S M Chang, et al.
Archives of Neurology|February 1, 1995
Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumorsM C Chamberlain, D Barba, P Kormanik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Extended CSF cytarabine exposure following intrathecal administration of DTC 101S Kim, E Chatelut, J C Kim, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Archives of Neurology|September 1, 1995
Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastasesM C Chamberlain, P Kormanik, S B Howell, et al.
Neurosurgery|October 1, 1988
Treatment of extraneural metastatic medulloblastoma with a combination of cyclophosphamide, adriamycin, and vincristineM C Chamberlain, P Silver, M S Edwards, et al.
Neuro-Oncology|April 18, 2001
Adult medulloblastoma: multiagent chemotherapyH S Greenberg, M C Chamberlain, M J Glantz, et al.
Journal of Neuro-Oncology|December 1, 1988
A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumorsM C Chamberlain, M D Prados, P Silver, et al.
American Journal of Clinical Oncology|February 1, 1988
A phase II trial of oral melphalan in recurrent primary brain tumorsM C Chamberlain, M D Prados, P Silver, et al.
Journal of Neuro-Oncology|March 1, 1996
Spindle cell hemangioendothelioma of the spinal cordZ Mahdavi, M R Grafe, R Ostrup, et al.
Archives of Neurology|March 1, 1993
Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I studyM C Chamberlain, S Khatibi, J C Kim, et al.
Seminars in Radiation Oncology|April 21, 1999
The role of paclitaxel in the treatment of primary and metastatic brain tumorsM J Glantz, M C Chamberlain, S M Chang, et al.
Archives of Neurology|February 1, 1995
Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumorsM C Chamberlain, D Barba, P Kormanik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Extended CSF cytarabine exposure following intrathecal administration of DTC 101S Kim, E Chatelut, J C Kim, et al.
Pageof 9